Titan Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Titan Pharmaceuticals is a pharmaceutical manufacturing company focused on developing proprietary therapeutics for serious medical disorders. Its lead product, Probuphine, relies on its ProNeura drug-delivery system to deliver continuous, six-month buprenorphine levels after a single procedure, and it received FDA approval in May 2016 with U.S. commercialization by Braeburn Pharmaceuticals. The company is based in South San Francisco, California, and maintains a relatively small to mid-sized team. The ProNeura technology is positioned to potentially address other chronic conditions where steady medication delivery could improve outcomes, with exploration into conditions such as Parkinson's disease and hypothyroidism. Titan has pursued partnerships and licensing arrangements to advance its pipeline, including a 2022 licensing agreement with Ocular Therapeutix. In October 2025, Titan Pharmaceuticals announced a merger with TalenTec Sdn. Bhd., resulting in Black Titan Corporation as the parent company.